Marais AD - Search Results

1

Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.

Marais AD, Naoumova RP, Firth JC, Penny C, Neuwirth CK, Thompson GR. Marais AD, et al. J Lipid Res. 1997 Oct;38(10):2071-8. J Lipid Res. 1997. PMID: 9374129 Free article. Clinical Trial.

2

Using changes in attributable risk to predict long-term efficacy of simvastatin treatment.

Vermaak WJ, Ubbink JB, Ungerer JP, Marais AD, Firth J, Van Lathem JM, Becker PJ. Vermaak WJ, et al. Among authors: marais ad. Clin Chem. 1992 Oct;38(10):2033-7. Clin Chem. 1992. PMID: 1394987

3

Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin.

Rubinsztein DC, Coetzee GA, Marais AD, Leitersdorf E, Seftel HC, van der Westhuyzen DR. Rubinsztein DC, et al. Among authors: marais ad. J Lipid Res. 1992 Nov;33(11):1647-55. J Lipid Res. 1992. PMID: 1464748 Free article.

4

Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas.

Graadt van Roggen F, van der Westhuyzen DR, Marais AD, Gevers W, Coetzee GA. Graadt van Roggen F, et al. Among authors: marais ad. Hum Genet. 1991 Dec;88(2):204-8. doi: 10.1007/BF00206073. Hum Genet. 1991. PMID: 1757095

5

Deletion of two growth-factor repeats from the low-density-lipoprotein receptor accelerates its degradation.

van der Westhuyzen DR, Stein ML, Henderson HE, Marais AD, Fourie AM, Coetzee GA. van der Westhuyzen DR, et al. Among authors: marais ad. Biochem J. 1991 Aug 1;277 ( Pt 3)(Pt 3):677-82. doi: 10.1042/bj2770677. Biochem J. 1991. PMID: 1872803 Free PMC article.

6

A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemia.

Steyn K, Weich HF, Vermaak WJ, Marais AD, Omar MA, Van Gelder AL, Fourie J, Kotze TJ, Stander I, Firth JC, et al. Steyn K, et al. Among authors: marais ad. S Afr Med J. 1991 Jun 1;79(11):639-45. S Afr Med J. 1991. PMID: 2047945 Clinical Trial.

7

Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.

Berger GM, Firth JC, Jacobs P, Wood L, Marais AD, Horak A. Berger GM, et al. Among authors: marais ad. Am J Med. 1990 Feb;88(2):94-100. doi: 10.1016/0002-9343(90)90455-m. Am J Med. 1990. PMID: 2105647

8

Fatal outcome of homozygous familial hypercholesterolaemia in a black patient. A case report.

Marais AD, Firth JC, Rose AG, Berger GM. Marais AD, et al. S Afr Med J. 1990 Jun 2;77(11):588-90. S Afr Med J. 1990. PMID: 2345887

9

New drugs for treating hypercholesterolemia and other hyperlipidaemias--the HMG CoA reductase inhibitors.

Berger GM, Marais AD, Firth JC. Berger GM, et al. Among authors: marais ad. S Afr Med J. 1990 Jan 20;77(2):57-9. S Afr Med J. 1990. PMID: 2404345 Review. No abstract available.

10

Treatment of hypercholesterolemia with the HMG CoA reductase inhibitor, simvastatin.

Berger GM, Marais AD, Seftel HC, Baker SG, Mendelsohn D, Welsh NH, Joffe BI. Berger GM, et al. Among authors: marais ad. Cardiovasc Drugs Ther. 1989 Apr;3(2):219-27. doi: 10.1007/BF01883868. Cardiovasc Drugs Ther. 1989. PMID: 2487533 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters